The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
Treating Opioid-Induced Constipation with Lubiprostone Won't Inhibit Analgesic Effects
Post-hoc analysis of phase III clinical study results finds lubiprostone doesn't interfere with the analgesic effect of opioids in chronic non-cancer pain patients with opioid-induced constipation.
Anxiety-Depression Disorder Aggravates Digestive Symptoms in IBS Patients
In a study published in Experimental and Therapeutic Medicine, a professor in the Department of Digestive System at Xingtai People's Hospital in China, investigated the correlation between psychological status and the mechanism of action of pro-inflammatory and anti-inflammatory cytokines in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
Ramosetron Shows Long-Term Efficacy in IBS-D without Alosetron's Adverse Side Effects
In a clinical review published in Clinical and Experimental Gastroenterology, researchers from Iwate Medical University in Japan evaluated the long-term safety and efficacy of the novel serotonin-receptor agonist ramosetron in patients suffering from diarrhea-predominant irritable bowel syndrome (IBS-D).
Oral vs. Intravenous Proton Pump Inhibitors in Patients with Peptic Ulcer Bleeding
August 27th 2013A recent meta-analysis indicates treatment with oral proton pump inhibitors (PPIs) produces outcomes similar to those obtained with treatment with intravenous PPIs in patients with peptic ulcer bleeding.
Gastric-Protective Aspirin Treatment Still Induces Peptic Ulcer
Even when it's administered in a low-dose form that resists gastric acid and prevents tablet dissolution in the stomach, aspirin therapy causes peptic ulcer and increases the risk of 30-day mortality resulting from gastrointestinal (GI) disorder progression.
Inadequate Vitamin D May Increase Risk of Certain Rheumatic Diseases
While substantial evidence already shows several genetic and environmental elements factor into immune-mediated rheumatic disease susceptibility, a recent review of hospital admissions data suggests vitamin D deficiency can single-handedly elevate a patient's risk of developing certain chronic conditions within that group of disorders.
H. pylori Protein Presence Boosts Risk of Peptic Ulcer Disease
Though they conducted their analysis in China, four researchers have successfully demonstrated a link between babA2 gene and peptic ulcer disease (PUD) in Helicobacter pylori-infected populations within countries located on the Western Hemisphere.
Study Finds Physicians Ignore Behavioral Therapy Referral Standards for IBS Management
Recognizing frustrations stemming from "the contested nature of the diagnosis, ineffective treatments, and a mismatch between general practitioner (GP) and patient explanatory models" for irritable bowel syndrome, a team of British researchers examined the tensions between how physicians approach IBS and what's currently recommended for diagnosing and managing the functional gastrointestinal disorder.
Hospital Performance Rankings Don't Capture Cancer Operation Complexity
Although many US hospitals tout quality improvement in surgical outcomes, new research findings released at the national conference of the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) show that taking cancer operation performance into account would deliver a more accurate hospital rating.
FDA Adds Sprue-Like Enteropathy Warning to Blood Pressure Drug Label
With strong clinical evidence and adverse event reports linking Daiichi Sankyo's high blood pressure medication Benicar (olmesartan medoxomil) to the gastrointestinal condition known as sprue-like enteropathy, the US Food and Drug Administration has approved changes for the drug's label to include a warning about that risk.
Researchers Test Correlation between IBS Symptoms and Methane, Hydrogen Gas Concentrations
Researchers at the Hanyang University College of Medicine set the record straight on the association between IBS symptoms and methane and hydrogen gas produced by intestinal fermentation of lactulose and excreted in the breath during lactulose breath test.
Postmenopausal Women with IBS-C Benefit from Melatonin More than IBS-D Counterparts
Recognizing that melatonin secretion from the gastrointestinal (GI) tract improves abdominal pain in irritable bowel syndrome (IBS) but decreases with age, Polish researchers from the Medical University of Lodz aimed to define the effect of administering melatonin in postmenopausal women with different predominating IBS symptoms.
Study: Every Hour of Surgical Delay Brings a Perforated Peptic Ulcer Patient Closer to Death
Though it's common medical knowledge that an ulcer eating a hole through a patient's stomach requires immediate surgical treatment as a result of its life-threatening nature, new findings from a team of Danish researchers urge physicians to beat the clock in performing emergency surgery on perforated peptic ulcers (PPU).
FDA Approves Hepatitis C Virus Genotyping Test for Physicians to Target Treatment
To help physicians take a step towards more personalized treatment for patients infected with hepatitis C virus (HCV), the US Food and Drug Administration today approved a fully automated test that can distinguish the seven major HCV genotypes in an infected patient.
Researcher Sorts Through Sea of IBS Remedies
May 22nd 2013As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that's still unknown, it's difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Colonoscopy Prevents Crohn's Disease Post-Operative Endoscopic Recurrence
May 22nd 2013While it's already clinically understood that most patients with Crohn's disease suffer a recurrence following an intestinal resection, researchers have not evaluated the best strategy to prevent the disease from recurring.